N
Norman Wolmark
Researcher at Allegheny General Hospital
Publications - 317
Citations - 41633
Norman Wolmark is an academic researcher from Allegheny General Hospital. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 92, co-authored 282 publications receiving 37852 citations. Previous affiliations of Norman Wolmark include MedStar Washington Hospital Center.
Papers
More filters
Journal ArticleDOI
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
David N. Krag,Stewart J. Anderson,Thomas B. Julian,Ann M. Brown,Seth P. Harlow,Joseph P. Costantino,Takamaru Ashikaga,Donald L. Weaver,Eleftherios P. Mamounas,Lynne M. Jalovec,Thomas G. Frazier,R. Dirk Noyes,André Robidoux,Hugh M.C. Scarth,Norman Wolmark +14 more
TL;DR: Overall survival, disease-free survival, and regional control were statistically equivalent between groups, and outcome analyses were done in patients who were assessed as having pathologically negative sentinel nodes and for whom follow-up data were available.
Journal ArticleDOI
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation
Bernard Fisher,Jong-Hyeon Jeong,Stewart J. Anderson,John Bryant,Edwin R. Fisher,Norman Wolmark +5 more
TL;DR: The findings validate earlier results showing no advantage from radical mastectomy and fail to show a significant survival advantage from removing occult positive nodes at the time of initial surgery or from radiation therapy.
Journal ArticleDOI
Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01.
Bernard Fisher,Norman Wolmark,Howard E. Rockette,Carol K. Redmond,Melvin Deutsch,D. Lawrence Wickerham,Edwin R. Fisher,Richard Caplan,Judith Jones,Harvey J. Lerner,Philip H. Gordon,Merrill I. Feldman,Anatolio B. Cruz,S Legault-Poisson,Marvin Wexler,Walter Lawrence,André Robidoux,Other Nsabp Investigators +17 more
TL;DR: Investigation of stratification variables employed in this study indicated that sex, and to a lesser extent age and Dukes stage, made individual contributions to the disease-free survival and the survival benefit from chemotherapy.
Journal ArticleDOI
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
B Fisher,James J. Dignam,Norman Wolmark,D. Lawrence Wickerham,Edwin R. Fisher,Eleftherios P. Mamounas,Roy E. Smith,Mirsada Begovic,Nikolay V. Dimitrov,Richard G. Margolese,Carl G Kardinal,Maureen T. Kavanah,Louis Fehrenbacher,Robert H Oishi +13 more
TL;DR: The combination of lumpectomy, radiation therapy, and tamoxifen was effective in the prevention of invasive cancer and the risk of ipsilateral-breast cancer was lower in the tamoxIFen group even when sample margins contained tumour and when DCIS was associated with comedonecrosis.
Journal ArticleDOI
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial
David N. Krag,Stewart J. Anderson,Thomas B. Julian,Ann M. Brown,Seth P. Harlow,Takamaru Ashikaga,Donald L. Weaver,Barbara J Miller,Lynne M. Jalovec,Thomas G. Frazier,R. Dirk Noyes,André Robidoux,Hugh M.C. Scarth,Denise M Mammolito,David R. McCready,Eleftherios P. Mamounas,Joseph P. Costantino,Norman Wolmark +17 more
TL;DR: In the B-32 trial as discussed by the authors, women with invasive breast cancer were randomly assigned to receive either axillary-lymph-node (SLN) resection followed by immediate conventional ALND or SLN resection without ALND if SLNs were negative on intraoperative cytology and histological examination.